PaceMate Appoints Cardiac Electrophysiologist as New Researcher

Dr. Benjamin A. Steinberg joins the team with NIH funding and expertise in heart rhythm disorders.

Apr. 7, 2026 at 1:42pm

A ghostly, translucent X-ray image of a human heart, revealing its intricate internal structure in glowing lines against a dark background, conceptually representing advancements in cardiac care technology.PaceMate's new cardiac electrophysiologist brings NIH-backed expertise to advance heart rhythm disorder research.Today in Tampa

PaceMate, a leading provider of cardiac monitoring and management solutions, has announced the appointment of Dr. Benjamin A. Steinberg as its new cardiac electrophysiologist and NIH-funded researcher. Dr. Steinberg brings extensive experience in the field of heart rhythm disorders and will play a key role in advancing PaceMate's research and development efforts.

Why it matters

Dr. Steinberg's appointment is a significant addition to PaceMate's team, as his expertise and NIH funding will help drive innovation in cardiac care technology. His research focus on heart rhythm disorders aligns with PaceMate's mission to provide cutting-edge solutions for patients with cardiac conditions.

The details

In his new role, Dr. Steinberg will be responsible for leading PaceMate's research initiatives, collaborating with the company's engineering and product teams to develop new cardiac monitoring and management solutions. His work will be supported by ongoing NIH funding, which he has secured for his research on heart rhythm disorders.

  • Dr. Steinberg's appointment at PaceMate was announced on April 7, 2026.

The players

PaceMate

A leading provider of cardiac monitoring and management solutions.

Dr. Benjamin A. Steinberg

A cardiac electrophysiologist and NIH-funded researcher who has joined PaceMate to lead the company's research and development efforts.

Got photos? Submit your photos here. ›

The takeaway

Dr. Steinberg's appointment at PaceMate is a significant step forward in the company's efforts to advance cardiac care technology, leveraging his expertise and NIH funding to drive innovation in the field of heart rhythm disorders.